COVID-19 EMERGENCY, SIFI PROVIDES ITALIAN HOSPITAL UNITS OF OPHTHALMOLOGY WITH PRODUCTS TO TREAT OCULAR DISCOMFORT AND PREVENT POTENTIAL RISKS OF INFECTION
Catania, Italy - March 23, 2020 - SIFI, the main Italian ophthalmic pharmaceutical company, is actively involved in the fight against COVID-19, and is alongside physicians, nurses and health personnel, to help face together the ongoing emergency. Therefore, multiple product donations are being sent to the ophthalmology departments of the main Italian hospitals, including sterile products for the treatment of ocular discomfort and for the prevention of potential risks of infection.
As seen in the COVID-19 Guidelines published by the American Academy of Ophthalmology (AAO) "several reports suggest the virus can cause conjunctivitis and possibly be transmitted by aerosol contact with conjunctiva. ". 1 The first doctor in China to diagnose the novel coronavirus was in fact an ophthalmologist, and he managed to locate the infection in the membrane of the eyes of infected patients.
SIFI wishes to help, both in fighting and minimizing risks of eye infections during such a crisis, and also in alleviating possible symptoms of dry eye in the health personnel, engaged relentlessly and in extreme labor conditions.
"Our wish is to help Italy's medical and healthcare workforce during these challenging times with a small but we hope significant gesture." said Fabrizio Chines, SIFI President and CEO "We want to show our support to the thousands of health professionals that are working to defeat the virus, with skill, courage, and relentlessly stamina."
SIFI is the leading Italian ophthalmic company, focused on eye care since 1935 with the mission to improve people’s lives through meaningful innovation in eye care. SIFI designs, manufactures and markets innovative pharmaceutical specialty products, nutraceuticals, surgical and medical devices. Headquartered in Catania, Sicily, SIFI operates directly in Italy, France, Spain, Romania, Turkey and Mexico with a staff of more than 400 people worldwide. Since June 2015, SIFI is backed by the private equity 21 Invest to support the company’s international expansion and portfolio development strategy. More information available at www.sifigroup.com.
1. AAO - Alert: Important coronavirus updates for ophthalmologists. Sources CDC, WHO https://www.aao.org/headline/alert-important-coronavirus-context
Press & Communication SIFI
email@example.com +39 3336999669